Novartis MS Drug Shows Promise in Clinical Trial Win

A new multiple sclerosis treatment from Novartis has achieved positive results in clinical trials, offering fresh hope to millions living with this challenging autoimmune disease.

The BTK inhibitor represents a promising advance in MS care.